SMARCC1/BAF155 (D7F8S) Rabbit Monoclonal… and 2 more items

The University of Nebraska Medical Center, a state agency in Nebraska, awarded a purchase order to Cell Signaling Technology Inc., a vendor based in Boston, Massachusetts, for the procurement of monoclonal antibody products. The contract, valued at $1,114.00, was executed on February 26, 2026, with a completion date of March 5, 2026. The contract encompasses three distinct monoclonal antibody line items: SMARCC1/BAF155 (D7F8S) Rabbit Monoclonal at $351.00, Rpb1 CTD (4H8) Mouse Monoclonal Antibody at $348.00, and Tri-Methyl-Histone H3 (Lys27) (C36B11) Rabbit Monoclonal at $415.00, with one unit of each item ordered.

Delivery of all materials was directed to the University of Nebraska Medical Center Shipping and Receiving facility located at 601 South Saddle Creek Road, Omaha, Nebraska, with unloading designated for DRCI 6054. The contract established a Net 30 payment term with F.O.B. destination freight prepaid pursuant to the Standard Terms of Purchase established by the University of Nebraska Board of Regents. The vendor was required to acknowledge acceptance within ten days of the order date and ensure that the purchase order number and all accompanying documentation appeared on packages, invoices, and packing slips.